Panel: Timing and Implications of FDA LDT Rule; Reforms to CLIA Regulations; Wider Use of Z-Code by Payers
Presented by: William Morice, Tim Stenzel, Lale White, Gabriel Bien-Willner
Laboratory & Pathology Merger & Acquisition Workshop – Panel—Lab Valuation Trends: What Factors Drive High Values and Multiples in Acquisitions of Independent Labs, Genetic Labs, and Pathology Groups
Presented by: Cory Roberts, Anil Asnani, Christal Contini, Chris Jahnle
Laboratory & Pathology Merger & Acquisition Workshop - Panel—Lab Valuation Trends: What Factors Drive High Values and Multiples in Acquisitions of Independent Labs, Genetic Labs, and Pathology Groups
PDF copy of the Presentation Slides
New Developments at the FDA: Draft LDT Rule, Harmonization of ISO 13485, Memo on Reclassification of Certain Assays, and More
Presented by: Timothy Stenzel
New Developments at the FDA: Draft LDT Rule, Harmonization of ISO 13485, Memo on Reclassification of Certain Assays, and More
PDF copy of the Presentation Slides
MolDx and Z-identifier Codes: Why and How and the Future
Presented by: Gabriel Bien-willner
MolDx and Z-identifier Codes: Why and How and the Future
PDF copy of the Presentation Slides
CDC Laboratory Update: CLIA Regulations, Resources for Clinical Laboratories, and More
Presented by: Reynolds Salerno
CDC Laboratory Update: CLIA Regulations, Resources for Clinical Laboratories, and More
PDF copy of the Presentation Slides
Big Changes in Healthcare: New Regulations and New Diagnostics Players Poised to Reshape Lab Testing
Presented by: Lale White
Big Changes in Healthcare: New Regulations and New Diagnostics Players Poised to Reshape Lab Testing
PDF copy of the Presentation Slides
